Trials / Completed
CompletedNCT01262586
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
Pilot Study to Assess the Difference in Glycemic Profiles Between Vildagliptin and Glimepiride Using Continuous Glucose Monitoring Device
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will use Continuous Glucose Monitoring to assess differences in glycemic profiles between vildagliptin and glimepiride.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vildagliptin | |
| DRUG | Glimepiride |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-12-17
- Last updated
- 2016-11-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01262586. Inclusion in this directory is not an endorsement.